Parkinson-Plus Syndromes: Introduction | Lecturio

This video introduces Parkinson-Plus Syndromes, a group of neurodegenerative disorders that present with Parkinson-like symptoms but have additional clinical features. It explains how these syndromes differ from classic Parkinson’s disease in terms of progression and response to treatment. You’ll explore the specific brain regions affected, such as the basal ganglia, brainstem, and cerebellum. The video helps build a foundation for recognizing and understanding these complex movement disorders.

Summary

Parkinson’s Plus Syndromes are conditions that mimic idiopathic Parkinson’s disease (PD) but have distinct underlying pathologies and clinical features. Unlike idiopathic PD, they are typically less responsive to Levodopa therapy, progress more rapidly, and include additional neurological symptoms that help distinguish them.

This article reviews the four major Parkinson’s Plus Syndromes—Lewy Body Dementia, Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration—along with their clinical hallmarks and neuropathology.

Table of Contents

Introduction: Parkinsonism vs Parkinson’s Plus

  • Idiopathic Parkinson’s Disease (PD):
    • Hallmarks: bradykinesia, rigidity, tremor, and postural instability.
    • Responsive to Levodopa.
  • Parkinson’s Plus Syndromes (Levodopa non-responsive):
    • Share Parkinsonian features (slowness, rigidity, instability).
    • Distinguished by additional symptoms and poor response to Levodopa.
    • Faster progression and greater disability.

Lewy Body Dementia (LBD)

  • Core features:
    • Early dementia (within 1 year of motor symptoms).
    • Visual hallucinations.
    • Severe neuroleptic (antipsychotic) sensitivity.
  • Supportive findings:
    • Fluctuating cognition.
    • Parkinsonian motor symptoms.
  • Pathology:
    • Alpha-synuclein deposition (Lewy bodies) extending into cortical regions.

Multiple System Atrophy (MSA)

  • Key early feature: Autonomic dysfunction
    • Orthostatic hypotension
    • Erectile dysfunction
    • Urinary incontinence
  • Motor phenotype:
    • Parkinsonism (striatonigral type) or cerebellar ataxia (MSA-C).
  • Other findings: Early falls, dysphagia, dysphonia.
  • Pathology:
    • Alpha-synuclein accumulation in oligodendrocytes.
    • Affects basal ganglia, brainstem, cerebellum, and autonomic pathways.

Progressive Supranuclear Palsy (PSP)

  • Clinical features:
    • Early, frequent falls.
    • Vertical gaze palsy (especially downward gaze).
    • Prominent axial rigidity (stiffness of trunk/neck).
    • Dysphagia, dysarthria.
  • Pathology:
    • Tau protein accumulation in brainstem and diencephalon.
    • Midbrain involvement explains gaze palsy.

Corticobasal Degeneration (CBD)

  • Unique characteristics:
    • Prominently asymmetric presentation.
    • Apraxia: inability to plan motor tasks despite intact strength.
    • Alien limb phenomenon: limb acts involuntarily, “foreign” to the patient.
    • Early visuospatial and cognitive deficits.
  • Pathology:
    • Tauopathy affecting parietal lobes and cortical sensory regions.

Idiopathic Parkinson’s vs PD Plus

  • Idiopathic PD:
    • Begins in brainstem (caudal medulla → substantia nigra).
    • Early: REM sleep behavior disorder, nausea.
    • Motor symptoms: basal ganglia involvement.
    • Late: dementia due to cortical Lewy body spread.
  • PD Plus Syndromes:
    • Differ based on distribution of pathology (alpha-synuclein vs tau; brainstem vs cortex vs cerebellum).
    • Explains their distinct clinical signatures.

Neuropathology Behind the Syndromes

  • Idiopathic PD & MSA: Alpha-synucleinopathies.
  • PSP & CBD: Tauopathies.
  • Affected brain regions determine presenting symptoms:
    • Brainstem/midbrain: Gaze palsy, early falls.
    • Parietal lobes: Apraxia, alien limb.
    • Autonomic centers: Orthostasis, incontinence.
    • Cortex: Dementia, hallucinations.

Conclusion

Parkinson’s Plus Syndromes are distinct clinical entities that share core Parkinsonian features but differ in presentation, response to therapy, and underlying pathology. Recognizing their unique clinical clues—early dementia in LBD, autonomic dysfunction in MSA, vertical gaze palsy in PSP, and asymmetric apraxia/alien limb in CBD—is crucial for accurate diagnosis and management.

Key Takeaways

  • All Parkinson’s Plus Syndromes feature bradykinesia, rigidity, and postural instability.
  • Lewy Body Dementia: Early dementia, hallucinations, neuroleptic sensitivity.
  • Multiple System Atrophy: Autonomic dysfunction, cerebellar/striatonigral involvement.
  • Progressive Supranuclear Palsy: Early falls, vertical gaze palsy, axial rigidity.
  • Corticobasal Degeneration: Asymmetric symptoms, apraxia, alien limb, cognitive decline.
  • Pathology:
    • Alpha-synucleinopathies: PD, MSA, LBD.
    • Tauopathies: PSP, CBD.
  • Recognizing where pathology starts in the brain helps explain the clinical picture.

Raw Transcript

[00:00] In this talk, let's review some of the Parkinson's plus syndromes. These are Parkinsonian syndromes patients present with a Parkinsonism, but they're not idiopathic PD. First, let's talk a little bit about Parkinsonisms. There are two basic Parkinsonisms.

[00:20] One is Levodopa responsive Parkinsonism and that's idiopathic PD. Those patients have bradykinesia, rigidity, postural instability, often with tremor, and they're readily responsive to Levodopa challenge. The second is Levodopa non-responsive Parkinsonisms. And these are our PD plus syndemics.

[00:40] that we'll review in this talk. Let's start with an overview of some of the common Parkinson's plus syndromes. And there's four that I'd like you to know. Lewy body dementia, multiple system atrophy, progressive supranuclear palsy, and corticobasal or corticobasal.

[01:00] corticobasal ganglionic degeneration. And there are a number of things that I want you to remember about these syndromes. Number one, they're all Parkinsonisms. So all four of these conditions present with bradykinesia, rigidity, and postural instability. That's really, really important to remember. However, there are also some

[01:20] unique features of each of these conditions that are unique to the condition and help us to establish the diagnosis. With Lewy body dementia, we see early dementia as a prominent feature in those patients. So dementia begins within one year of the development of Parkinsonian symptoms. We can also see hallucinosis.

[01:40] in these patients and neuroleptic sensitivity is common. We use neuroleptics to manage some of the symptoms we can see when patients are hallucinating or agitated and these patients will develop severe sensitivity and become agitated and confused and may need hospitalization as a result of initiation of neuroleptics.

[02:00] are supportive of a diagnosis of Lewy body dementia. Next, multiple system atrophy. The key features to this syndrome is early autonomic dysfunction. So we think about orthostasis, erectile dysfunction, and incontinence. And early findings, any of those three findings, early in the course of

[02:20] of the Parkinsonism should prompt the consideration for multiple system atrophy.

[02:40] and we see falling. In Parkinson's disease, falls are late and PSP falls are early. This is also an axial, a kinetic, rigid Parkinsonism. So patients have difficulty moving and they are very, very rigid, often in the axial musculature that controls our posture and axial tone.

[03:00] Patients may have other brainstem symptoms, dysphagia or oral dyskinesias or dysphonia. And then lastly, corticobasal degeneration, this is a really unique and kind of strange, uniquely strange syndrome. Here we see that it's prominently asymmetric. Patients begin with very asymmetric symptoms.

[03:20] symptoms and we see a few things, apraxia, alien hand and cognitive deficits, and this owes to its predilection for the parietal lobes. Apraxia is motor planning, so these patients are able to move, but they just can't form the plan for how to do it and what they need to do. Alien limb is an extreme,

[03:40] of that where a patient's limb will be alien to them. It will shave on its own, it will cook on its own, it will write things that the patient doesn't want to write. It literally is alien, it does what it wants to do, and the patient does not appear to be in control. Those findings of early visuospatial dysfunction and early asymmetric apraxia

[04:00] or alien limb should raise suspicion for corticobasal degeneration. Let's walk through each of these and understand why each of these Parkinsonisms presents differently and look at the areas of brain that are involved. First I want to look at idiopathic PD, and the problem that we think about

[04:20] as in the substantia nigra, paris compacta, but it actually begins way down deep in the brainstem early. So the development of Lewy bodies, that degenerative pathology that's developing in the brain, begins down in the caudal medulla. And that early caudal medulla dysfunction likely leads to early reminiscence.

[04:40] behavior disorder. Slowly over time we see increase in Lewy body deposition further higher up in the brainstem and the pons and ultimately in the basal ganglia contributing to the motor development of symptoms and then over time into the cortex where patients will develop a late dementia, Parkinson's disease dementia.

[05:00] and other cognitive dysfunction. So again, early in the disease for idiopathic PD, we see REM behavior disorder and nausea. In the typical presentation, we see the motor symptoms as the subcortical basal ganglia structures are involved. And then late in the course of the disease, as Lewy bodies develop in the cortex, we see dementia and other cortical dysfunction.

[05:20] in these patients. This is different from progressive supranuclear palsy and the distribution of neurodegeneration differs for PSP and helps us to determine what symptoms we see when patients present and things we wanna look out for. PSP is a tauopathy, so the structure is a tau.

[05:40] that's developing within the neurons, the degeneration that's occurring is a result of buildup of tau. And we see tau deposition in the brainstem. And you can see in the upper diencephalon here, there is frequent deposition of tau. And this gives rise to the vertical gaze dysfunction. The vertical gaze center is in the upper midbrain.

[06:00] as well as prominent axial rigidity that we see in this condition. We can contrast that to multiple system atrophy. And you can see the brain regions involved in multiple system atrophy. It is many, many multiple brain regions. And we can see predominance in one area or the other, but we often see that.

[06:20] see in this condition deposition of abnormal protein in both the subcortex, the brain stem, and in the brain. MSA is alpha-synucleonopathy and so the deposition that we're seeing is alpha-synuclein. In some cases the alpha-synuclein develops and builds up in the cerebellum and we may see a

[06:40] an MSA cerebellar type. In other cases, it primarily affects the subcortical basal ganglia, and we can see an MSA striatonigral or Parkinsonian type. And lastly, we can see problems in the deep brain stem, and this gives rise to an MSAA or autonomic type.

[07:00] Lastly, let's look at corticobasal degeneration and understand the brain regions that are affected by this condition. This is also a tauopathy, and so we're dealing with development of tau protein and deposition of tau. And you can see here the prominent involvement of the parietal lobes, giving rise to the higher level cortical sensory findings.

[07:20] in these patients, including that allium limb syndrome. ["The End of the World"]

[07:40] you

Related Episodes

Leave a Reply

Your email address will not be published. Required fields are marked *